Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Prasad, S. Kalafat, E. Blakeway, H. Townsend, R. O'Brien, P. Morris, E. Draycott, T. Thangaratinam, S. Le Doare, K. Ladhani, S. von Dadelszen, P. Magee, L. A. Heath, P. Khalil, A.

Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2022 ∙ Ludvigsson, J. F. Loboda, A.

Systematic review of health and disease in Ukrainian children highlights poor child health and challenges for those treating refugees

  • Europe
  • Ukraine
  • Newborn
  • Children
  • Adolescents
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Sitaras, I. Jacobsen, H. Higdon, M. M. Dowling, W. E. Bar-Zeev, N. Deloria Knoll, M.

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lane, S. Yeomans, A. Shakir, S.

Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Middleton, B. F. Fathima, P. Snelling, T. L. Morris, P.

Systematic review of the effect of additional doses of oral rotavirus vaccine on immunogenicity and reduction in diarrhoeal disease among young children

  • Newborn
  • Children
  • Rotavirus
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Izurieta, P. Scherbakov, M. Nieto Guevara, J. Vetter, V. Soumahoro, L.

Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Jordan, K. Murchu, E. O. Comber, L. Hawkshaw, S. Marshall, L. O’Neill, M. Teljeur, C. Harrington, P. Carnahan, A. Pérez-Martín, J. J. Robertson, A. H. Johansen, K. Jonge, J. D. Krause, T. Nicolay, N. Nohynek, H. Pavlopoulou, I. Pebody, R. Penttinen, P. Soler-Soneira, M. Wichmann, O. Ryan, M.

Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2022 ∙ Comber, L. O Murchu, E. Jordan, K. Hawkshaw, S. Marshall, L. O'Neill, M. Teljeur, C. Ryan, M. Carnahan, A. Pérez Martín, J. J. Robertson, A. H. Johansen, K. de Jonge, J. Krause, T. Nicolay, N. Nohynek, H. Pavlopoulou, I. Pebody, R. Penttinen, P. Soler-Soneira, M. Wichmann, O. Harrington, P.

Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2022 ∙ O Murchu, E. Comber, L. Jordan, K. Hawkshaw, S. Marshall, L. O’Neill, M. Ryan, M. Teljeur, C. Carnahan, A. Pérez, J. J. Robertson, A. H. Johansen, K. Jonge, J. D. Krause, T. Nicolay, N. Nohynek, H. Pavlopoulou, I. Pebody, R. Penttinen, P. Soler-Soneira, M. Wichmann, O. Harrington, P.

Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ O Murchu, E. Comber, L. Jordan, K. Hawkshaw, S. Marshall, L. O’Neill, M. Ryan, M. Teljeur, C. Carnahan, A. Pérez, J. J. Robertson, A. H. Johansen, K. Jonge, J. D. Krause, T. Nicolay, N. Nohynek, H. Pavlopoulou, I. Pebody, R. Penttinen, P. Soler-Soneira, M. Wichmann, O. Harrington, P.

Systematic review of the efficacy, effectiveness and safety of recombinant haemagglutinin seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...